top of page






Louisiana Gastroenterology Society.png
Society Endorsements


*Agenda is subject to change.

8:00 AM – 9:00 AM CDT


9:00 AM – 9:10 AM CDT


Lawrence Schiller, MD

9:10 AM – 9:35 AM CDT

Viral Hepatitis B & C: Diagnosis, Management, and Monitoring

Mark Sulkowski, MD 

9:35 AM – 10:00 AM CDT

COVID-19 and Liver Disease: What We’ve Learned So Far

Rita Lepe, MD

10:00 AM – 10:25 AM CDT

Managing Complications of Cirrhosis: Hepatic Encephalopathy and Hepatorenal Syndrome

Steven Flamm, MD

10:25 AM – 10:45 AM CDT

Q&A Panel Discussion

10:45 AM – 11:00 AM CDT


11:00 AM – 11:30 AM CDT

Hepatocellular Cancer: Screening and Treatment Recommendations

Laura Kulik, MD

11:30 AM – 12:00 PM CDT

Biologics and Small Molecule Therapy for IBD: Practical Approaches to Selecting Therapies

Anita Afzali MD, MPH

12:00 PM – 12:20 PM CDT

Q&A / Panel Discussion

12:20 PM - 12:30 PM CDT

Lunch Break


12:30 PM – 1:30 PM CDT

Lunch Product Theater (Non-Accredited)

Rising to the Challenge: Addressing Barriers to HCV Treatment
Parvez Mantry, MD, AGAF

Sponsored by: AbbVie

1:30 PM – 2:30 PM CDT

Parallel Sessions (Select One)

  • Management of GERD and H. Pylori Eradication

  • Case Studies in Inflammatory Bowel Disease (IBD)

  • Detecting and Treating GI and Liver Cancers

  • Diagnosing and Management of Non-alcoholic Fatty Liver Disease (NAFLD) / Non-alcoholic Steatohepatitis (NASH)


2:30 PM – 2:45 PM CDT


2:45 PM – 3:10 PM CDT


Lawrence Schiller, MD

3:10 PM – 3:35 PM CDT

Eosinophilic Gastrointestinal Disorders

Stuart Spechler, MD

3:35 PM – 4:00 PM CDT

Latest Advances in Enteroscopy

Daniel Demarco, MD

4:00 PM – 4:25 PM CDT

Diagnosing and Treating IBS-C, OIC, and Chronic Constipation

Lawrence Schiller, MD

4:25 PM – 4:40 PM CDT

Q&A / Panel Discussion

4:40 PM – 4:45 PM CDT





Lawrence Schiller, MD (Course Director)

Program Director, Gastroenterology Fellowship

Baylor University Medical Center

Dallas, Texas

Anita Afzali, MD, MPH, FACG, AGAF

Associate Professor of Medicine
Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease
Medical Director, OSU Inflammatory Bowel Disease Center
Program Director, OSU Advanced Inflammatory Bowel Disease Fellowship
Division of Gastroenterology, Hepatology and Nutrition
The Ohio State University Wexner Medical Center
Columbus, Ohio

Daniel Demarco, MD

Baylor Scott & White Research Institute
Dallas, Texas

Steven Flamm, MD

Chief of Hepatology and Liver Transplantation Program
Professor of Medicine and Surgery
Northwestern Feinberg School of Medicine
Chicago, Illinois

Laura Kulik, MD

Professor of Medicine
Transplant Surgery and Interventional Radiology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Rita Lepe, MD

Director, Hepatology Health Disparities Studies
Assistant Professor of Medicine UT Health San Antonio
Texas Liver Institute
Dallas, Texas

Stuart Spechler, MD

Chief, Division of Gastroenterology
Co-Director, Center for Esophageal Diseases
Baylor University Medical Center at Dallas
Co-Director, Center for Esophageal Research
Baylor Scott & White Research Institute
Dallas, Texas

Mark Sulkowski, MD

Professor of Medicine
Chief, Division of Infectious Diseases
John Hopkins University, Bayview Medical Center
Baltimore, Maryland



Westin Dallas Park Central 12720 Merit Drive

Dallas, TX 75251



GALA remains diligent in ensuring that the safety and security of our attendees, speakers and staff are top priority while planning the conference. As we move ahead with planning the conference, GALA will continue to place high importance on facilitating measures that will ensure optimal health and sanitary conditions for everyone onsite. COVID-19 state rules and regulations will be strictly followed.

Our onsite safety measures include the following:

  • Social distancing will be strictly followed with a limited number of attendees onsite.

  • Attendees must wear a face covering during the event.

  • Attendees are required to be six feet apart at all times; the conference organizers have arranged seating accordingly to be in compliance with this mandate.

  • Hand sanitizer stations have been placed throughout the meeting space, as well as in the hotel.

  • Signage is being used throughout the meeting space and hotel as a reminder to wear a mask and maintain social distance.

  • Commonly touched surfaces will be cleaned and disinfected by staff as often as possible.

  • Check-in for the event will be socially distanced and managed by the conference organizers for a “touchless” process.

  • Audience questions will be asked through our conference app to eliminate contact through handheld microphones.

  • To ensure the safety of our speakers, in between speaker presentations, there will be a slight delay while the podium, slide advancer, and microphone cover are sanitized.

  • All meals and break items will be served by the hotel staff in accordance with their individual COVID-19 safety procedures and standards.  

  • In addition to the safety measures outlined above, please CLICK HERE for a complete list of safety measures that the Westin Dallas Park Central has implemented.

COVID-19 Safety Notice
bottom of page